KIM HUSSEY: Open Payments
NPI 1245878636 · TROY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,959 in 123 payments from 18 companies in 2025. Trend: 2023 $1,117 · 2024 $1,492 · 2025 $1,959
Food & beverage: $1,904Education: $55
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $281 |
| UCB, Inc. | 25 | $264 |
| Janssen Biotech, Inc. | 17 | $209 |
| GENZYME CORPORATION | 10 | $181 |
| LEO Pharma Inc. | 11 | $165 |
| Arcutis Biotherapeutics, Inc. | 11 | $164 |
| PFIZER INC. | 10 | $151 |
| Stemline Therapeutics Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, Zoryve, CIBINQO, Orserdu, ADBRY.
Industry payments across AL — which companies pay providers there.
